Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryDifferential pharmacology and clinical utility of empagliflozin in type 2 diabetesBasal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision makingTreatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonistsLixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes.Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study.Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.Effects of Exercise in the Fasted and Postprandial State on Interstitial Glucose in Hyperglycemic Individuals.Impact of postprandial hyperglycemia at clinic visits on the incidence of cardiovascular events and all-cause mortality in patients with type 2 diabetes.BRIGHT Guidelines on Self-Monitoring of Blood Glucose.A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study.Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?The immediate effects of a single bout of aerobic exercise on oral glucose tolerance across the glucose tolerance continuumA review of cardiovascular outcomes in the treatment of people with type 2 diabetes.HbA1C variability and the risk of renal status progression in Diabetes Mellitus: a meta-analysis.Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome.Utility of different glycemic control metrics for optimizing management of diabetesGlucose and triglyceride excursions following a standardized meal in individuals with diabetes: ELSA-Brasil study.Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study.Importance of Beta Cell Function for the Treatment of Type 2 DiabetesGlycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetes.One bout of exercise alters free-living postprandial glycemia in type 2 diabetesFast food increases postprandial cardiac workload in type 2 diabetes independent of pre-exercise: A pilot studyHigh glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets.Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality.Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial.Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study.The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries.Understanding Post-Prandial Hyperglycemia in Patients with Type 1 and Type 2 Diabetes: A Web-based Survey in Germany, the UK, and USA.Effects of different proportion of carbohydrate in breakfast on postprandial glucose excursion in normal glucose tolerance and impaired glucose regulation subjects.Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker rats.Frequent interruptions of sedentary time modulates contraction- and insulin-stimulated glucose uptake pathways in muscle: Ancillary analysis from randomized clinical trials.Ideal glycated hemoglobin cut-off points for screening diabetes and prediabetes in a Chinese population.Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials.Orange Pomace Improves Postprandial Glycemic Responses: An Acute, Randomized, Placebo-Controlled, Double-Blind, Crossover Trial in Overweight Men.Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus.A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress.The role of self-monitoring of blood glucose in glucagon-like peptide-1-based treatment approaches: a European expert recommendation.The role of oxidative stress in postprandial endothelial dysfunction.
P2860
Q22241786-B4EFE9C3-54CE-4697-B084-2E7B8E9F9FBFQ26749281-B07B74B9-7F3C-4697-AF83-A26EC2B7B11EQ26992979-FE0C5F39-7101-45AB-98C3-CF40557958CFQ28077026-EC95671D-9738-48C2-B959-F3090CE82A63Q30253045-36AD0173-B771-4174-8120-6AC985EA8602Q30666747-CA33EE90-EE0E-4544-B257-BC8FFED2BD34Q33629805-F7D38B91-82E7-4309-8A2A-DD9E42B50C3EQ33727475-DBA1F641-D382-4128-B69E-76693FE5EBBDQ33782775-9C26C65C-3D20-4F75-9E75-528C76CBEEE8Q33871377-6247B5F9-E5EE-4065-9B38-AC8C1C780218Q34176357-5C6E1092-2F75-41C3-95C8-6E859EA9E502Q34329486-1107D893-AA29-4C56-BAAC-FD8CC8801E4AQ34486820-E1EB3DD5-D750-4CD2-B007-2E831309AAD7Q34582349-BB3A917D-1710-4335-9891-3D34DA07C33CQ34726469-5DA94A56-0622-4850-AE1F-3B46F80946EDQ34734227-D617711B-BF81-4585-8AAC-72A390E5C802Q34999016-E0B717A4-8936-43DC-A566-B3252C837119Q35049855-CE575E42-D34F-4320-B3C8-4064F8FD119FQ35085599-A438516C-7169-4900-B050-03D57344A568Q35117192-8DA83F66-BF73-4B35-9889-608A7B6BC709Q35667116-51E0AF32-7655-4E72-9327-9193F5023B61Q35845203-F4393000-42B2-4A28-B153-6E3189F4EA7FQ35907035-A5219CF7-0FC7-4D75-90B3-AAE1C54C0ECCQ35949618-41D8F2AC-00DC-4315-8970-FC3B9750B8A0Q36339645-59849EC3-A88D-4512-A653-D033BF9C821BQ36392849-1D8165E8-F15C-4A7A-816D-8A5E8C124C64Q36633079-4EBFF724-7511-47CA-9250-5842CB5D2D9BQ36682246-01A65918-C08D-4E6D-BB0B-9DEA801585ACQ36712197-7501BE97-4654-4F5B-90E0-6B38D325AC73Q36989716-F9EC551F-FD4C-44E8-8B8B-346333A51C15Q37006655-A399730F-1D6A-4B8F-BD2B-78E899758274Q37033531-766DB2E1-70FA-43C6-9175-1D84DD33F137Q37198711-909CF17A-E61B-4FE9-ABAF-74683CC8001EQ37227381-EACF4C2C-1B3D-4C74-B0B8-43CFA6597669Q37568863-A268834B-9655-4F76-B2D1-EC1A1B8D15C0Q37673197-976E979D-3D29-4A01-97DB-0DB00A180D54Q37692779-F0E27E01-F204-4B39-B91B-B3C7FBE5D319Q37694033-0F4863FF-0D4D-4E6F-8DA2-50DE30C7DC70Q38024383-F201DB98-A1AD-4E42-8AF3-658329D98555Q38061799-A728ED5C-B0D2-439C-99B6-CA8054588343
P2860
Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Postprandial blood glucose pre ...... n Luigi Gonzaga Diabetes Study
@ast
Postprandial blood glucose pre ...... n Luigi Gonzaga Diabetes Study
@en
type
label
Postprandial blood glucose pre ...... n Luigi Gonzaga Diabetes Study
@ast
Postprandial blood glucose pre ...... n Luigi Gonzaga Diabetes Study
@en
prefLabel
Postprandial blood glucose pre ...... n Luigi Gonzaga Diabetes Study
@ast
Postprandial blood glucose pre ...... n Luigi Gonzaga Diabetes Study
@en
P2093
P2860
P356
P1433
P1476
Postprandial blood glucose pre ...... n Luigi Gonzaga Diabetes Study
@en
P2093
Andrea Pagliarino
Giovanni Anfossi
Katia Bonomo
Leonardo Di Martino
Manuela Valle
Paola Massucco
P2860
P304
P356
10.2337/DC10-2414
P407
P577
2011-10-01T00:00:00Z